Kiora Other Operating Expenses from 2010 to 2024
| KPRX Stock | USD 0.47 0.01 2.08% |
Other Operating Expenses | First Reported 2013-03-31 | Previous Quarter 2.5 M | Current Value 2 M | Quarterly Volatility 1.1 M |
Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora main balance sheet or income statement drivers, such as Depreciation And Amortization of 59.3 K, Selling General Administrative of 4.4 K or Other Operating Expenses of 10 M, as well as many exotic indicators such as Price To Sales Ratio of 1.8 K, Dividend Yield of 0.0 or PTB Ratio of 0.43. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.
Kiora | Other Operating Expenses |
Latest Kiora Pharmaceuticals' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Kiora Pharmaceuticals over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Kiora Pharmaceuticals. It is also known as Kiora Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Kiora Pharmaceuticals' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Kiora Other Operating Expenses Regression Statistics
| Arithmetic Mean | 8,689,847 | |
| Geometric Mean | 7,784,620 | |
| Coefficient Of Variation | 43.14 | |
| Mean Deviation | 3,041,303 | |
| Median | 8,690,183 | |
| Standard Deviation | 3,748,733 | |
| Sample Variance | 14.1T | |
| Range | 12.5M | |
| R-Value | 0.54 | |
| Mean Square Error | 10.7T | |
| R-Squared | 0.30 | |
| Significance | 0.04 | |
| Slope | 455,287 | |
| Total Sum of Squares | 196.7T |
Kiora Other Operating Expenses History
About Kiora Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Kiora Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Kiora Pharmaceuticals investors use historical funamental indicators, such as Kiora Pharmaceuticals's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Kiora Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Kiora Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kiora Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kiora Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 8.7 M | 10 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Kiora Pharmaceuticals Correlation against competitors. For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Kiora Stock analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 0.002 | Return On Assets (0.34) | Return On Equity (1.43) |
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.